Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemia. (2013)

First Author: Oram SH
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/leu.2013.2

PubMed Identifier: 23302769

Publication URI: http://europepmc.org/abstract/MED/23302769

Type: Journal Article/Review

Volume: 27

Parent Publication: Leukemia

Issue: 6

ISSN: 0887-6924